8 Feb 2026
Biopolymer-stabilized zein nanoparticles for pressure ulcer management: Formulation, optimization, and preliminary in vivo assessmentPublisher siteJournal of Pharmaceutical Sciences, Wound Healing and Treatments
Active, last published 2026
6
H-index
126
Citations
Wessam has not officially claimed their profile. If you are Wessam, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Wessam M. El-Refaie will appear here once their profile is updated.
02 · Reach
Publication output and reach
Wessam's work has been cited 126 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchPharos University in Alexandria, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
10 works30 Jul 2025
Development of arsenic nanoparticles: a novel topical therapy for psoriasis enhancing skin deposition and preventing relapse for long-term efficacy in imiquimod-induced rat modelPublisher siteInternational Journal of Pharmaceutics, Retinoids in leukemia and cellular processes
22 May 20257cites
Intra-articular metformin-curcumin cationic PLGA nanoparticles rejuvenate articular structure in MIA induced osteoarthritis model via modulating the crosstalk between miR93, TNFAIP3/TLR/NF-κB and AMPK/SIRT1 trajectoriesPublisher siteInternational Journal of Biological Macromolecules, Osteoarthritis Treatment and Mechanisms
9 May 20255cites
Rationally designed Pyrazolo[1,5-a]pyrimidines as dual inhibitors of CA IX/XII and CDK6: A novel approach for NSCLC treatmentPublisher siteEuropean Journal of Medicinal Chemistry, Advanced Breast Cancer Therapies
18 Oct 20244cites
Targeted non-invasive Metformin-Curcumin co-loaded nanohyaluosomes halt osteoarthritis progression and improve articular cartilage structure: A preclinical studyPublisher siteInternational Journal of Pharmaceutics, Curcumin's Biomedical Applications
31 Jul 2024Open access8cites
Valsartan as a prophylactic treatment against breast cancer development and niche activation: What molecular sequels follow chronic AT-1R blockade?Publisher siteLife Sciences, Renin-Angiotensin System Studies
13 Mar 2024Open access7cites
Non-invasive caffeinated-nanovesicles as adipocytes-targeted therapy for cellulite and localized fatsPublisher siteInternational Journal of Pharmaceutics X, Body Contouring and Surgery
1 Aug 2023Open access17cites
Rhein methotrexate-decorated solid lipid nanoparticles altering adjuvant arthritis progression through endoplasmic reticulum stress-mediated apoptosisPublisher siteInflammopharmacology, Rheumatoid Arthritis Research and Therapies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Wessam?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you